Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LY3143921 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor with broad in vitro anticancer activity [1].
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 10,500 | |||
5 mg | 在庫あり | ¥ 22,500 | |||
10 mg | 在庫あり | ¥ 33,000 | |||
25 mg | 在庫あり | ¥ 55,500 | |||
50 mg | 在庫あり | ¥ 84,000 | |||
100 mg | 在庫あり | ¥ 128,500 |
説明 | LY3143921 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor with broad in vitro anticancer activity [1]. |
分子量 | 327.31 |
分子式 | C16H14FN5O2 |
CAS No. | 1627696-53-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 65 mg/mL(198.59 mM)
Ethanol: 32 mg/mL(97.77mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LY3143921 hydrate 1627696-53-0 Cell Cycle/Checkpoint CDK LY3143921 Hydrate LY-3143921 hydrate LY 3143921 Hydrate LY-3143921 Hydrate Inhibitor inhibitor inhibit